Ingela Ahlstedt

BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Adipose stem cells are sexually dimorphic cells with dual roles as preadipocytes and resident fibroblasts.

Adipose stem cells are sexually dimorphic cells with dual roles as preadipocytes and resident fibroblasts.

Journal: Nature communications
Published: July 31, 2023

FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.

FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.

Journal: eLife
Published: August 30, 2022

TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis.

TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis.

Journal: Nature communications
Published: January 05, 2022

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.

Journal: Molecular metabolism
Published: December 08, 2018

Targeted delivery of antisense oligonucleotides to pancreatic β-cells.

Targeted delivery of antisense oligonucleotides to pancreatic β-cells.

Journal: Science advances
Published: February 15, 2018

Modeling human pancreatic beta cell dedifferentiation.

Modeling human pancreatic beta cell dedifferentiation.

Journal: Molecular metabolism
Published: January 08, 2018

Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells.

Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells.

Journal: Scientific reports
Published: January 12, 2016

Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.

Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.

Journal: PloS one
Published: July 07, 2014
Showing 1-8 of 8

Last Updated: 09/26/2026